Ra Medical stock rises ~10% on Japanese patent linked to imaging system

Mar. 17, 2023 8:31 AM ETRa Medical Systems, Inc (RMED)By: Ravikash, SA News Editor

Ra Medical Systems (NYSE:RMED) said its unit Catheter Precision will get a patent in Japan linked to the company's VIVO technology.
The patent is titled, 'Methods of Cardiac Mapping and Model Merging.'
VIVO is a non-invasive 3D imaging system which helps physicians to identify the origin of ventricular arrhythmias pre-procedure.
Ventricular arrhythmias are abnormal heartbeats which start in the lower heart chambers known as ventricles. This cause the heart to beat too fast.
"We are pleased that our technology in the field of cardiac electrophysiology continues to be recognized as unique and different," said Ra Medical's Executive Chairman David Jenkins.
RMED +9.94% to $2.10 premarket March 17